Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 09:31 am Purchase | 2024-09-30 | 13G | Ascendis Pharma A/S ASND | Avoro Capital Advisors LLC | 4,988,888 8.200% | 1,233,333 (+32.84%) | Filing History |
| 2024-11-14 09:30 am Purchase | 2024-09-30 | 13G | Kymera Therapeutics, Inc. KYMR | Avoro Capital Advisors LLC | 7,750,000 9.990% | 3,975,000 (+105.30%) | Filing History |
| 2024-04-23 6:22 pm Sale | 2023-12-31 | 13G | Spyre Therapeutics, Inc. SYRE | Avoro Capital Advisors LLC | 1,839,138 5.100% | -286,459 (-13.48%) | Filing History |
| 2024-02-14 09:25 am Purchase | 2023-12-31 | 13G | Krystal Biotech, Inc. KRYS | Avoro Capital Advisors LLC | 2,565,555 9.100% | 1,155,555 (+81.95%) | Filing History |
| 2024-02-14 09:23 am Purchase | 2023-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS | Avoro Capital Advisors LLC | 13,411,111 9.900% | 2,786,111 (+26.22%) | Filing History |
| 2024-02-14 09:22 am Purchase | 2023-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | Avoro Capital Advisors LLC | 27,400,000 9.300% | 600,000 (+2.24%) | Filing History |
| 2024-02-14 09:21 am Purchase | 2023-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | Avoro Capital Advisors LLC | 2,288,888 9.900% | 628,888 (+37.88%) | Filing History |
| 2024-02-14 09:20 am Sale | 2023-12-31 | 13G | Mersana Therapeutics, Inc. MRSN | Avoro Capital Advisors LLC | 0 0.000% | -7,550,000 (Position Closed) | Filing History |
| 2024-02-14 09:18 am Sale | 2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | Avoro Capital Advisors LLC | 0 0.000% | -3,060,000 (Position Closed) | Filing History |
| 2024-02-14 09:17 am Purchase | 2023-12-31 | 13G | Ascendis Pharma A/S ASND | Avoro Capital Advisors LLC | 3,755,555 6.500% | 655,555 (+21.15%) | Filing History |
| 2024-02-14 09:15 am Sale | 2023-12-31 | 13G | Kymera Therapeutics, Inc. KYMR | Avoro Capital Advisors LLC | 3,775,000 6.800% | -75,000 (-1.95%) | Filing History |
| 2024-02-14 09:14 am Purchase | 2023-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE | Avoro Capital Advisors LLC | 4,535,000 9.100% | 210,000 (+4.86%) | Filing History |
| 2024-02-14 09:13 am Sale | 2023-12-31 | 13G | Mirati Therapeutics, Inc. MRTX | Avoro Capital Advisors LLC | 4,886,840 7.000% | -668,715 (-12.04%) | Filing History |
| 2024-02-14 09:12 am Purchase | 2023-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE | Avoro Capital Advisors LLC | 5,666,666 7.700% | 766,666 (+15.65%) | Filing History |
| 2024-02-14 09:10 am Purchase | 2023-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Avoro Capital Advisors LLC | 6,583,332 9.990% | 6,583,332 (New Position) | Filing History |
| 2024-02-14 09:09 am Purchase | 2023-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY | Avoro Capital Advisors LLC | 16,337,739 9.990% | 3,537,739 (+27.64%) | Filing History |
| 2024-02-14 09:08 am Purchase | 2023-12-31 | 13G | Spyre Therapeutics, Inc. SYRE | Avoro Capital Advisors LLC | 2,125,597 5.900% | 2,125,597 (New Position) | Filing History |
| 2024-02-14 09:07 am Purchase | 2023-12-31 | 13G | Structure Therapeutics Inc. GPCR | Avoro Capital Advisors LLC | 6,999,999 5.000% | 6,999,999 (New Position) | Filing History |
| 2024-02-14 09:05 am Sale | 2023-12-31 | 13G | United Therapeutics Corporation UTHR | Avoro Capital Advisors LLC | 2,858,888 6.100% | -6,112 (-0.21%) | Filing History |
| 2024-02-14 09:04 am Unchanged | 2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Avoro Capital Advisors LLC | 3,150,000 5.800% | 0 (Unchanged) | Filing History |